Indoxyl sulfate (IS)-mediated immune dysfunction provokes endothelial damage in patients with end-stage renal disease (ESRD)

Explore this paper's citation graph

Summary

It is suggested that in ESRD, IS-mediated immune dysfunction may cause vascular endothelial cell damage and thus, this toxin plays a pivotal role in the pathogenesis of CVD.

Type
article
Published
2017-06-08
Cited by
114
References
73
Access
Open access

Keywords

Geography

References

Cited by

Related papers